acetylcysteine has been researched along with Psoriasis in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (55.56) | 29.6817 |
| 2010's | 4 (44.44) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ayala, F; Balato, A; Balato, N; Caiazzo, G; Di Caprio, R; Fortunato, G; Lembo, S; Monfrecola, G; Raimondo, A; Schiattarella, M | 1 |
| Choi, EJ; Hong, MP; Kie, JH; Kim, HR; Lee, A; Lee, HK; Lim, W; Moon, BI; Seoh, JY | 1 |
| David, M; Gilhar, A; Keren, A | 1 |
| Ahmad, SF; Al-Harbi, MM; Al-Harbi, NO; Alotaibi, MR; AlSaad, AM; Ansari, MA; Nadeem, A | 1 |
| Boehncke, WH; Elliott, PJ; Zollner, TM | 1 |
| Beyerle, A; Meves, A; Peus, D; Pittelkow, MR; Pott, M; Vasa, M | 1 |
| Bock, D; Philipp, S; Wolff, G | 1 |
| Borkin, MS; Boyd, SL; Koepke, JI; Terlecky, LJ; Terlecky, SR; Young, CN | 1 |
| Boehncke, WH; Elliott, PJ; Kaufmann, R; Pien, C; Podda, M; Zollner, TM | 1 |
2 review(s) available for acetylcysteine and Psoriasis
| Article | Year |
|---|---|
Proteasome inhibition: a new anti-inflammatory strategy.
Topics: Acetylcysteine; Animals; Anti-Inflammatory Agents; Antineoplastic Agents; Arthritis, Rheumatoid; Asthma; Boronic Acids; Bortezomib; Clinical Trials as Topic; Cysteine Endopeptidases; Disease Models, Animal; Humans; Inflammation; Lysine; Models, Biological; Models, Chemical; Multienzyme Complexes; Multiple Sclerosis; Neoplasms; NF-kappa B; Peptides; Protease Inhibitors; Proteasome Endopeptidase Complex; Psoriasis; Pyrazines; Reperfusion Injury | 2003 |
Therapeutic potential of selectin antagonists in psoriasis.
Topics: Acetylcysteine; Animals; Dermatologic Agents; Dimethyl Fumarate; Fumarates; Gene Expression Regulation; Glycoproteins; Glycosphingolipids; Glycosylation; Humans; Leukocyte Rolling; Leukocytes; Ligands; Models, Animal; Protease Inhibitors; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Protein Processing, Post-Translational; Psoriasis; Randomized Controlled Trials as Topic; Selectins | 2006 |
7 other study(ies) available for acetylcysteine and Psoriasis
| Article | Year |
|---|---|
Paraoxonases and psoriasis: negative imbalance of antioxidant endogenous mechanisms.
Topics: Acetylcysteine; Adult; Antioxidants; Aryldialkylphosphatase; Case-Control Studies; Female; Gene Expression Regulation; Humans; Hydrogen Peroxide; Male; Middle Aged; Oxidative Stress; Psoriasis; Severity of Illness Index | 2019 |
Reactive oxygen species prevent imiquimod-induced psoriatic dermatitis through enhancing regulatory T cell function.
Topics: Acetylcysteine; Aminoquinolines; Animals; Dermatitis; Disease Progression; Glutathione Peroxidase; Glutathione Peroxidase GPX1; Hyperbaric Oxygenation; Imiquimod; Indoleamine-Pyrrole 2,3,-Dioxygenase; Mice, Inbred C57BL; NADPH Oxidases; Naphthoquinones; Psoriasis; Reactive Oxygen Species; T-Lymphocytes, Regulatory | 2014 |
Novel nanosome delivery system combined with siRNA targeting the antimicrobial gene DFB4: a new approach for psoriasis management?
Topics: Acetylcysteine; Animals; beta-Defensins; Disease Models, Animal; Drug Delivery Systems; Epidermis; Gene Silencing; Humans; Mice; Nanomedicine; Nanoparticles; Phenotype; Psoriasis; RNA, Small Interfering; Skin Transplantation | 2014 |
Psoriasis-like inflammation leads to renal dysfunction via upregulation of NADPH oxidases and inducible nitric oxide synthase.
Topics: Acetylcysteine; Aminoquinolines; Animals; Antioxidants; Buthionine Sulfoximine; Disease Models, Animal; Humans; Imiquimod; Inflammation; Kidney; Kidney Diseases; Male; Membrane Glycoproteins; Mice; Mice, Inbred BALB C; NADPH Oxidase 2; NADPH Oxidase 4; NADPH Oxidases; Nitric Oxide Synthase Type II; Oxidative Stress; Psoriasis | 2017 |
Antipsoriatic drug anthralin induces EGF receptor phosphorylation in keratinocytes: requirement for H(2)O(2) generation.
Topics: Acetylcysteine; Anthralin; Anti-Inflammatory Agents; Antioxidants; Catalase; Cells, Cultured; Electroporation; ErbB Receptors; Humans; Hydrogen Peroxide; Keratinocytes; Kinetics; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Phosphorylation; Phosphotyrosine; Psoriasis; Recombinant Proteins; Signal Transduction | 2004 |
Reactive oxygen species in tumor necrosis factor-alpha-activated primary human keratinocytes: implications for psoriasis and inflammatory skin disease.
Topics: Acetylcysteine; Antioxidants; Catalase; Cells, Cultured; Free Radical Scavengers; Humans; Hydrogen Peroxide; I-kappa B Proteins; Interleukin-6; Interleukin-8; Keratinocytes; Male; Protein Kinases; Psoriasis; Reactive Oxygen Species; Signal Transduction; Sirolimus; Skin Diseases; Taurine; TOR Serine-Threonine Kinases; Transcription Factor RelA; Tumor Necrosis Factor-alpha | 2008 |
Proteasome inhibition reduces superantigen-mediated T cell activation and the severity of psoriasis in a SCID-hu model.
Topics: Acetylcysteine; Animals; Antigens, CD; Antigens, Differentiation, T-Lymphocyte; Bacterial Toxins; Cysteine Endopeptidases; Cysteine Proteinase Inhibitors; Disease Models, Animal; DNA; Enterotoxins; HLA-DR Antigens; Humans; Lectins, C-Type; Lymphocyte Activation; Mice; Mice, SCID; Multienzyme Complexes; NF-kappa B; Proteasome Endopeptidase Complex; Psoriasis; Receptors, Interleukin-2; Skin Transplantation; Superantigens; T-Lymphocytes; Transplantation, Heterologous | 2002 |